Detalhe da pesquisa
1.
Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease.
Ann Neurol
; 89(3): 587-597, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349939
2.
Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's Disease.
Mov Disord
; 37(6): 1211-1221, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238430
3.
Long-term independence and quality of life after subthalamic stimulation in Parkinson disease.
Eur J Neurol
; 29(9): 2645-2653, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666167
4.
Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs.
Mov Disord
; 36(12): 2888-2900, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494685
5.
Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.
Mov Disord
; 34(11): 1644-1654, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309609
6.
Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease.
Hum Brain Mapp
; 39(12): 5014-5027, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259598
7.
Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.
J Neurol Neurosurg Psychiatry
; 89(8): 836-843, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29436490
8.
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
Mov Disord
; 33(12): 1878-1886, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30444952
9.
Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.
Rev Neurol (Paris)
; 174(9): 653-663, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224159
10.
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
Mov Disord
; 32(11): 1566-1573, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28737225
11.
Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.
Mov Disord
; 32(8): 1191-1200, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643887
12.
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
Brain
; 139(Pt 9): 2486-502, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538418
13.
Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 87(3): 311-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934016
14.
Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.
J Neurol Neurosurg Psychiatry
; 86(2): 186-90, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24860137
15.
Is Motor Side Onset of Parkinson's Disease a Risk Factor for Developing Impulsive-Compulsive Behavior? A Cross-Sectional Study.
Mov Disord
; 35(6): 1080-1081, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32311121
16.
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Brain
; 136(Pt 5): 1568-77, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23543483
17.
Psychostimulant effect of levodopa: reversing sensitisation is possible.
J Neurol Neurosurg Psychiatry
; 84(1): 18-22, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22991345
18.
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Brain
; 135(Pt 5): 1463-77, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508959
19.
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.
Sci Rep
; 13(1): 21234, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040775
20.
Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.
J Parkinsons Dis
; 12(5): 1665-1676, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527563